Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Midgley

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Nature Reviews. Cancer|June 19, 2009
Genetic prognostic and predictive markers in colorectal cancerAxel Walther, Elaine Johnstone, Charles Swanton, et al.
Cell Cycle (Georgetown, Tex.)|August 27, 2013
TGF-β: an emerging player in drug resistanceDiede Brunen, Stefan M Willems, Udo Kellner, et al.
Oncoscience|June 23, 2015
Methylation changes in the TFAP2E promoter region are associated with BRAF mutation and poorer overall & disease free survival in colorectal cancerAndrew D Beggs, Mark P Dilworth, Enric Domingo, et al.
Investigational New Drugs|June 5, 2012
Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumorsGary K Schwartz, Richard D Carvajal, Rachel Midgley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancerEnric Domingo, David N Church, Oliver Sieber, et al.
Journal of Human Genetics|November 26, 2010
Cyclin D1 rare variants in UK multiple adenoma and early-onset colorectal cancer patientsCarolina Bonilla, Jérémie H Lefèvre, Bruce Winney, et al.
Journal of Human Genetics|August 10, 2012
Role of rare variants in undetermined multiple adenomatous polyposis and early-onset colorectal cancerJérémie H Lefevre, Carolina Bonilla, Chrystelle Colas, et al.
Oncotarget|November 17, 2012
Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CINAndrew D Beggs, Enric Domingo, Megan McGregor, et al.
Science Translational Medicine|July 16, 2010
Quinone oxidoreductase-2-mediated prodrug cancer therapyMark R Middleton, Richard Knox, Emma Cattell, et al.
The Journal of Pathology|November 21, 2012
Use of multivariate analysis to suggest a new molecular classification of colorectal cancerEnric Domingo, Rajarajan Ramamoorthy, Dahmane Oukrif, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Nature Reviews. Cancer|June 19, 2009
Genetic prognostic and predictive markers in colorectal cancerAxel Walther, Elaine Johnstone, Charles Swanton, et al.
Cell Cycle (Georgetown, Tex.)|August 27, 2013
TGF-β: an emerging player in drug resistanceDiede Brunen, Stefan M Willems, Udo Kellner, et al.
Oncoscience|June 23, 2015
Methylation changes in the TFAP2E promoter region are associated with BRAF mutation and poorer overall & disease free survival in colorectal cancerAndrew D Beggs, Mark P Dilworth, Enric Domingo, et al.
Investigational New Drugs|June 5, 2012
Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumorsGary K Schwartz, Richard D Carvajal, Rachel Midgley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancerEnric Domingo, David N Church, Oliver Sieber, et al.
Journal of Human Genetics|November 26, 2010
Cyclin D1 rare variants in UK multiple adenoma and early-onset colorectal cancer patientsCarolina Bonilla, Jérémie H Lefèvre, Bruce Winney, et al.
Journal of Human Genetics|August 10, 2012
Role of rare variants in undetermined multiple adenomatous polyposis and early-onset colorectal cancerJérémie H Lefevre, Carolina Bonilla, Chrystelle Colas, et al.
Oncotarget|November 17, 2012
Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CINAndrew D Beggs, Enric Domingo, Megan McGregor, et al.
Science Translational Medicine|July 16, 2010
Quinone oxidoreductase-2-mediated prodrug cancer therapyMark R Middleton, Richard Knox, Emma Cattell, et al.
The Journal of Pathology|November 21, 2012
Use of multivariate analysis to suggest a new molecular classification of colorectal cancerEnric Domingo, Rajarajan Ramamoorthy, Dahmane Oukrif, et al.
Pageof 3